TransMedics Stock 104% Over: Is 2026 the Next Breakout?
TransMedics has surged 104% over the last year, catching investors’ eyes. This guide breaks down the business, the ca...
An overview of where to locate stock index listings worldwide, with guidance on finding the right benchmarks for your analysis.
17,106 articlesTransMedics has surged 104% over the last year, catching investors’ eyes. This guide breaks down the business, the ca...
The past year reshaped The Trade Desk in ways that matter to investors. This article breaks down what changed, why it...
Planet Labs delivered its first full year of profitability, with a ballooning backlog and AI partnerships driving a r...
A hedge fund recently boosted its position in 10x Genomics, highlighting growing confidence in the biotech tools make...
Microsoft’sAI push fuels cloud and enterprise gains even as capital outlays rise and OpenAI losses widen. Analysts ma...
A major fund recently reduced its exposure to Adaptive Biotechnologies, sparking questions about what institutional m...
As travel demand rebounds, investors want clarity on which cruise stock to buy in 2026. This guide contrasts Royal Ca...
Pricing power has long been Apple’s ace. Now the company faces a no-win pricing trap: raise prices risking demand, or...
A biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
TeraWulf stock this year has surged as the company pivots from crypto mining to long-term compute infrastructure afte...
July has brought headlines that test investors' nerves. This piece breaks down what drove stock moves today, what Luc...
Biotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...